Evaluation of Alpha-1 antitrypsin level in the serum of children with idiopathic bronchiectasis

Background: Bronchiectasis is a clinical syndrome characterized by chronic cough, sputum production, recurrent respiratory infections, and permanent bronchial dilation.  The association between the level of alpha-1 antitrypsin (AAT) and bronchiectasis is controversial. In this study, we aimed to inv...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Maryam Babaei, Zahra Kanannejad, Soheila Alyasin
Formato: article
Lenguaje:EN
Publicado: Tehran University of Medical Sciences 2021
Materias:
Acceso en línea:https://doaj.org/article/e64febfcf6b54a14bd303b8af532add3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e64febfcf6b54a14bd303b8af532add3
record_format dspace
spelling oai:doaj.org-article:e64febfcf6b54a14bd303b8af532add32021-11-29T06:16:21ZEvaluation of Alpha-1 antitrypsin level in the serum of children with idiopathic bronchiectasis0044-60251735-969410.18502/acta.v59i11.7775https://doaj.org/article/e64febfcf6b54a14bd303b8af532add32021-11-01T00:00:00Zhttps://acta.tums.ac.ir/index.php/acta/article/view/9233https://doaj.org/toc/0044-6025https://doaj.org/toc/1735-9694Background: Bronchiectasis is a clinical syndrome characterized by chronic cough, sputum production, recurrent respiratory infections, and permanent bronchial dilation.  The association between the level of alpha-1 antitrypsin (AAT) and bronchiectasis is controversial. In this study, we aimed to investigate this association in children with idiopathic bronchiectasis. Methods:  The study was conducted on 20 patients with idiopathic bronchiectasis as the case group (mean age 15.9±2.1) and 20 healthy individuals as the control group (mean age 14.9±2.6). Serum AAT level was measured using nephelometric analysis (g/L). Other criteria including sex, parent consanguinity, number of hospitalization, age of the first symptom were evaluated in both groups related to AAT level. Results: The mean serum level of AAT in the case and control groups were 1.3±0.29; 1.5 ±0.59, respectively with statistical significance (P=0.001). There was a significant difference between the two groups in the AAT level distribution, according to AAT normal range (p=0.01). The case group had a more positive attitude toward consanguinity than the control group (66.7% versus 33.3%; P<0.001). The results showed that 80% of patients had the first symptom of disease under 1 year of age, 6.6% 1- 5 years, 6.6% 5- 10 years, and 6.6% in more than 10 years old. In the case group, 53.3% had a history of medical hospitalization for one time, 26.7% two times, while 20% of the patients had no medical hospitalization. Conclusion: Decreased AAT serum level and high consanguinity rates may be considered as two risk factors for idiopathic bronchiectasis occurrence in children.Maryam BabaeiZahra KanannejadSoheila AlyasinTehran University of Medical Sciencesarticlealpha-1 antitrypsinidiopathic bronchiectasisnephelometryMedicine (General)R5-920ENActa Medica Iranica, Pp 641-644 (2021)
institution DOAJ
collection DOAJ
language EN
topic alpha-1 antitrypsin
idiopathic bronchiectasis
nephelometry
Medicine (General)
R5-920
spellingShingle alpha-1 antitrypsin
idiopathic bronchiectasis
nephelometry
Medicine (General)
R5-920
Maryam Babaei
Zahra Kanannejad
Soheila Alyasin
Evaluation of Alpha-1 antitrypsin level in the serum of children with idiopathic bronchiectasis
description Background: Bronchiectasis is a clinical syndrome characterized by chronic cough, sputum production, recurrent respiratory infections, and permanent bronchial dilation.  The association between the level of alpha-1 antitrypsin (AAT) and bronchiectasis is controversial. In this study, we aimed to investigate this association in children with idiopathic bronchiectasis. Methods:  The study was conducted on 20 patients with idiopathic bronchiectasis as the case group (mean age 15.9±2.1) and 20 healthy individuals as the control group (mean age 14.9±2.6). Serum AAT level was measured using nephelometric analysis (g/L). Other criteria including sex, parent consanguinity, number of hospitalization, age of the first symptom were evaluated in both groups related to AAT level. Results: The mean serum level of AAT in the case and control groups were 1.3±0.29; 1.5 ±0.59, respectively with statistical significance (P=0.001). There was a significant difference between the two groups in the AAT level distribution, according to AAT normal range (p=0.01). The case group had a more positive attitude toward consanguinity than the control group (66.7% versus 33.3%; P<0.001). The results showed that 80% of patients had the first symptom of disease under 1 year of age, 6.6% 1- 5 years, 6.6% 5- 10 years, and 6.6% in more than 10 years old. In the case group, 53.3% had a history of medical hospitalization for one time, 26.7% two times, while 20% of the patients had no medical hospitalization. Conclusion: Decreased AAT serum level and high consanguinity rates may be considered as two risk factors for idiopathic bronchiectasis occurrence in children.
format article
author Maryam Babaei
Zahra Kanannejad
Soheila Alyasin
author_facet Maryam Babaei
Zahra Kanannejad
Soheila Alyasin
author_sort Maryam Babaei
title Evaluation of Alpha-1 antitrypsin level in the serum of children with idiopathic bronchiectasis
title_short Evaluation of Alpha-1 antitrypsin level in the serum of children with idiopathic bronchiectasis
title_full Evaluation of Alpha-1 antitrypsin level in the serum of children with idiopathic bronchiectasis
title_fullStr Evaluation of Alpha-1 antitrypsin level in the serum of children with idiopathic bronchiectasis
title_full_unstemmed Evaluation of Alpha-1 antitrypsin level in the serum of children with idiopathic bronchiectasis
title_sort evaluation of alpha-1 antitrypsin level in the serum of children with idiopathic bronchiectasis
publisher Tehran University of Medical Sciences
publishDate 2021
url https://doaj.org/article/e64febfcf6b54a14bd303b8af532add3
work_keys_str_mv AT maryambabaei evaluationofalpha1antitrypsinlevelintheserumofchildrenwithidiopathicbronchiectasis
AT zahrakanannejad evaluationofalpha1antitrypsinlevelintheserumofchildrenwithidiopathicbronchiectasis
AT soheilaalyasin evaluationofalpha1antitrypsinlevelintheserumofchildrenwithidiopathicbronchiectasis
_version_ 1718407618257485824